Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report.
Stent thrombosis is a rare but potentially fatal complication of percutaneous treatment of coronary disease. Its occurrence after placement of drug eluting stents (DES) has raised concerns, as this event may occur very late after stent implantation. Here, we report a case of very late stent thrombosis (VLST) experienced 1462 days after DES deployment in a patient with challenging clinical status, requiring counterbalancing hemorrhagic and thrombotic risk factors.
Esposito
Giovanni
G
Division of Cardiology, Federico II University, Naples, Italy.
Cassese
Salvatore
S
Gargiulo
Giuseppe
G
Sannino
Anna
A
Schiattarella
Gabriele Giacomo
GG
Piscione
Federico
F
Chiariello
Massimo
M
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D017023:Coronary Angiography; D004334:Drug Administration Schedule; D054855:Drug-Eluting Stents; D004562:Electrocardiography; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel